View in EDS

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.

Saved in:
Bibliographic Details
Title: Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Authors: Albain KS; Loyola University Chicago Stritch School of Medicine, Maywood, Illinois., Yau C; University of California San Francisco, San Francisco, California., Petricoin EF; George Mason University, Fairfax, Virginia., Wolf DM; University of California San Francisco, San Francisco, California., Lang JE; Cleveland Clinic, Cleveland, Ohio., Chien AJ; University of California San Francisco, San Francisco, California., Haddad T; Mayo Clinic Rochester, Rochester, Minnesota., Forero-Torres A; University of Alabama at Birmingham, Birmingham, Alabama., Wallace AM; University of California San Diego, La Jolla, California., Kaplan H; Swedish Cancer Institute, Seattle, Washington., Pusztai L; Yale University, New Haven, Connecticut., Euhus D; Johns Hopkins University, Baltimore, Maryland., Nanda R; University of Chicago, Chicago, Illinois., Elias AD; University of Colorado Denver, Aurora, Colorado., Clark AS; University of Pennsylvania, Philadelphia, Pennsylvania., Godellas C; Loyola University Chicago Stritch School of Medicine, Maywood, Illinois., Boughey JC; Mayo Clinic Rochester, Rochester, Minnesota., Isaacs C; Georgetown University, Washington, District of Columbia., Tripathy D; University of Texas MD Anderson Cancer Center, Houston, Texas., Lu J; University of Southern California, Los Angeles, California., Yung RL; University of Washington, Seattle, Washington., Gallagher RI; George Mason University, Fairfax, Virginia., Wulfkuhle JD; George Mason University, Fairfax, Virginia., Brown-Swigart L; University of California San Francisco, San Francisco, California., Krings G; University of California San Francisco, San Francisco, California., Chen YY; University of California San Francisco, San Francisco, California., Potter DA; University of Minnesota, Minneapolis, Minnesota., Stringer-Reasor E; University of Alabama at Birmingham, Birmingham, Alabama., Blair S; University of California San Diego, La Jolla, California., Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, California., Wilson A; Quantum Leap Healthcare Collaborative, San Francisco, California., Hirst GL; University of California San Francisco, San Francisco, California., Singhrao R; University of California San Francisco, San Francisco, California., Buxton M; University of California San Francisco, San Francisco, California., Clennell JL; University of California San Francisco, San Francisco, California., Sanil A; Berry Consultants, LLC, Houston, Texas., Berry S; Berry Consultants, LLC, Houston, Texas., Asare AL; Quantum Leap Healthcare Collaborative, San Francisco, California., Matthews JB; University of California San Francisco, San Francisco, California., DeMichele AM; University of Pennsylvania, Philadelphia, Pennsylvania., Hylton NM; University of California San Francisco, San Francisco, California., Melisko M; University of California San Francisco, San Francisco, California., Perlmutter J; Gemini Group, Ann Arbor, Michigan., Rugo HS; University of California San Francisco, San Francisco, California., Symmans WF; University of Texas MD Anderson Cancer Center, Houston, Texas., Van't Veer LJ; University of California San Francisco, San Francisco, California., Yee D; University of Minnesota, Minneapolis, Minnesota., Berry DA; Berry Consultants, LLC, Houston, Texas., Esserman LJ; University of California San Francisco, San Francisco, California.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Feb 16; Vol. 30 (4), pp. 729-740.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38109213
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Albain+KS%22">Albain KS</searchLink>; Loyola University Chicago Stritch School of Medicine, Maywood, Illinois.<br /><searchLink fieldCode="AU" term="%22Yau+C%22">Yau C</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Petricoin+EF%22">Petricoin EF</searchLink>; George Mason University, Fairfax, Virginia.<br /><searchLink fieldCode="AU" term="%22Wolf+DM%22">Wolf DM</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Lang+JE%22">Lang JE</searchLink>; Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Chien+AJ%22">Chien AJ</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Haddad+T%22">Haddad T</searchLink>; Mayo Clinic Rochester, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Forero-Torres+A%22">Forero-Torres A</searchLink>; University of Alabama at Birmingham, Birmingham, Alabama.<br /><searchLink fieldCode="AU" term="%22Wallace+AM%22">Wallace AM</searchLink>; University of California San Diego, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Kaplan+H%22">Kaplan H</searchLink>; Swedish Cancer Institute, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Pusztai+L%22">Pusztai L</searchLink>; Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Euhus+D%22">Euhus D</searchLink>; Johns Hopkins University, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Nanda+R%22">Nanda R</searchLink>; University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Elias+AD%22">Elias AD</searchLink>; University of Colorado Denver, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Clark+AS%22">Clark AS</searchLink>; University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Godellas+C%22">Godellas C</searchLink>; Loyola University Chicago Stritch School of Medicine, Maywood, Illinois.<br /><searchLink fieldCode="AU" term="%22Boughey+JC%22">Boughey JC</searchLink>; Mayo Clinic Rochester, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Isaacs+C%22">Isaacs C</searchLink>; Georgetown University, Washington, District of Columbia.<br /><searchLink fieldCode="AU" term="%22Tripathy+D%22">Tripathy D</searchLink>; University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Lu+J%22">Lu J</searchLink>; University of Southern California, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Yung+RL%22">Yung RL</searchLink>; University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Gallagher+RI%22">Gallagher RI</searchLink>; George Mason University, Fairfax, Virginia.<br /><searchLink fieldCode="AU" term="%22Wulfkuhle+JD%22">Wulfkuhle JD</searchLink>; George Mason University, Fairfax, Virginia.<br /><searchLink fieldCode="AU" term="%22Brown-Swigart+L%22">Brown-Swigart L</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Krings+G%22">Krings G</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Chen+YY%22">Chen YY</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Potter+DA%22">Potter DA</searchLink>; University of Minnesota, Minneapolis, Minnesota.<br /><searchLink fieldCode="AU" term="%22Stringer-Reasor+E%22">Stringer-Reasor E</searchLink>; University of Alabama at Birmingham, Birmingham, Alabama.<br /><searchLink fieldCode="AU" term="%22Blair+S%22">Blair S</searchLink>; University of California San Diego, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Asare+SM%22">Asare SM</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Wilson+A%22">Wilson A</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Hirst+GL%22">Hirst GL</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Singhrao+R%22">Singhrao R</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Buxton+M%22">Buxton M</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Clennell+JL%22">Clennell JL</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Sanil+A%22">Sanil A</searchLink>; Berry Consultants, LLC, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Berry+S%22">Berry S</searchLink>; Berry Consultants, LLC, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Asare+AL%22">Asare AL</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Matthews+JB%22">Matthews JB</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22DeMichele+AM%22">DeMichele AM</searchLink>; University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Hylton+NM%22">Hylton NM</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Melisko+M%22">Melisko M</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Perlmutter+J%22">Perlmutter J</searchLink>; Gemini Group, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Symmans+WF%22">Symmans WF</searchLink>; University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Van't+Veer+LJ%22">Van't Veer LJ</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Yee+D%22">Yee D</searchLink>; University of Minnesota, Minneapolis, Minnesota.<br /><searchLink fieldCode="AU" term="%22Berry+DA%22">Berry DA</searchLink>; Berry Consultants, LLC, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Esserman+LJ%22">Esserman LJ</searchLink>; University of California San Francisco, San Francisco, California.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2024 Feb 16; Vol. 30 (4), pp. 729-740.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38109213
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-22-2256
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 729
    Titles:
      – TitleFull: Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Albain KS
      – PersonEntity:
          Name:
            NameFull: Yau C
      – PersonEntity:
          Name:
            NameFull: Petricoin EF
      – PersonEntity:
          Name:
            NameFull: Wolf DM
      – PersonEntity:
          Name:
            NameFull: Lang JE
      – PersonEntity:
          Name:
            NameFull: Chien AJ
      – PersonEntity:
          Name:
            NameFull: Haddad T
      – PersonEntity:
          Name:
            NameFull: Forero-Torres A
      – PersonEntity:
          Name:
            NameFull: Wallace AM
      – PersonEntity:
          Name:
            NameFull: Kaplan H
      – PersonEntity:
          Name:
            NameFull: Pusztai L
      – PersonEntity:
          Name:
            NameFull: Euhus D
      – PersonEntity:
          Name:
            NameFull: Nanda R
      – PersonEntity:
          Name:
            NameFull: Elias AD
      – PersonEntity:
          Name:
            NameFull: Clark AS
      – PersonEntity:
          Name:
            NameFull: Godellas C
      – PersonEntity:
          Name:
            NameFull: Boughey JC
      – PersonEntity:
          Name:
            NameFull: Isaacs C
      – PersonEntity:
          Name:
            NameFull: Tripathy D
      – PersonEntity:
          Name:
            NameFull: Lu J
      – PersonEntity:
          Name:
            NameFull: Yung RL
      – PersonEntity:
          Name:
            NameFull: Gallagher RI
      – PersonEntity:
          Name:
            NameFull: Wulfkuhle JD
      – PersonEntity:
          Name:
            NameFull: Brown-Swigart L
      – PersonEntity:
          Name:
            NameFull: Krings G
      – PersonEntity:
          Name:
            NameFull: Chen YY
      – PersonEntity:
          Name:
            NameFull: Potter DA
      – PersonEntity:
          Name:
            NameFull: Stringer-Reasor E
      – PersonEntity:
          Name:
            NameFull: Blair S
      – PersonEntity:
          Name:
            NameFull: Asare SM
      – PersonEntity:
          Name:
            NameFull: Wilson A
      – PersonEntity:
          Name:
            NameFull: Hirst GL
      – PersonEntity:
          Name:
            NameFull: Singhrao R
      – PersonEntity:
          Name:
            NameFull: Buxton M
      – PersonEntity:
          Name:
            NameFull: Clennell JL
      – PersonEntity:
          Name:
            NameFull: Sanil A
      – PersonEntity:
          Name:
            NameFull: Berry S
      – PersonEntity:
          Name:
            NameFull: Asare AL
      – PersonEntity:
          Name:
            NameFull: Matthews JB
      – PersonEntity:
          Name:
            NameFull: DeMichele AM
      – PersonEntity:
          Name:
            NameFull: Hylton NM
      – PersonEntity:
          Name:
            NameFull: Melisko M
      – PersonEntity:
          Name:
            NameFull: Perlmutter J
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Symmans WF
      – PersonEntity:
          Name:
            NameFull: Van't Veer LJ
      – PersonEntity:
          Name:
            NameFull: Yee D
      – PersonEntity:
          Name:
            NameFull: Berry DA
      – PersonEntity:
          Name:
            NameFull: Esserman LJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 02
              Text: 2024 Feb 16
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1